News

MENADNA And Nebula Genomics Enter New Partnership

The venture will offer Whole Genome Sequencing in Jordan, Oman, and Iraq, with Saudi Arabia to follow.

Published

10 months ago

March 19, 2024

menadna and nebula genomics enter new partnership

MENADNA, a leading bioinformatics and genetic testing startup focused in the Middle East and North Africa (MENA) region, has announced a new commercial partnership with Nebula Genomics, a trailblazer in personalized genome sequencing. The high-level collaboration sees MENADNA added as an exclusive partner of Nebula Genomics in Jordan, Oman, and Iraq, with plans already in place for further expansion into Saudi Arabia in the near future.

The partnership will cover an extra 56 million people across the region, and by leveraging the advanced sequencing technologies of Nebula Genomics, MENADNA hopes to expand and upgrade its proprietary bioinformatics platform for what has historically been an underserved region.

The MENA represents a very diverse genetic landscape but is currently underrepresented in global genome-wide association studies (GWAS), which predominantly feature European ancestries. The collaboration aims to contribute valuable data from the region’s population, enriching global genetic databases and advancing local research.

Dr. Bassam El Fahmawi, CEO of MENADNA, shared his vision and enthusiasm for the partnership: “Our collaboration with Nebula Genomics is a game-changer for genomic testing in Jordan, Oman, and Iraq. By combining Nebula’s state-of-the-art sequencing technology with our specialized bioinformatics pipeline, we can provide more accurate, region-specific genomic insights. This is crucial, as less than 2% of genomic data available today comes from the region despite its rich genetic diversity. Our joint efforts will not only enhance patient care but also significantly contribute to the global understanding of genetic variations and their impact on health”.

Also Read: Dubai Police Reveal New 10-Minute Drug Testing Device

Jason Karkus, President of Nebula Genomics, also commented: “Nebula Genomics, a global pioneer in Whole Genome Sequencing, is pleased to partner with MENADNA, bringing our cutting edge, low-cost technology to Jordan, Oman, and Iraq. This is an exciting partnership, which we believe will lead to a substantial business relationship between our companies. Our combined expertise in Whole Genome Sequencing, proprietary reporting, bioinformatics, and large-scale distribution in the region, make us a perfect match for this strategic partnership”.

Related Topics:HealthTech MENA MENADNA Nebula Genomics

Up Next

Halo Space Capsule Set To Fly 32 Km Above Saudi Arabia

Don't Miss

Intel’s New Core i9 Desktop CPU Breaks Another Speed Record

Click to comment

News

Cemplicity Is Bringing Real-Time Patient Insights To The UAE

The advanced healthcare platform offers tools for chronic disease management and improved patient experiences.

Published

8 hours ago

January 13, 2025

Nour Nasir

Cemplicity

Cemplicity — a leading health-tech company founded in 2013 — has launched its advanced platform in the UAE, aiming to revolutionize patient care and streamline healthcare operations to improve clinical outcomes.

Designed to analyze patient-reported data in real-time, the platform incorporates Patient-Reported Experience Measures (PREMs) and Patient-Reported Outcome Measures (PROMs) to collect and analyze patient feedback. By transforming the data into actionable insights, healthcare providers will be better equipped to improve quality of care and increase efficiency.

Cemplicity’s technology can even tackle chronic conditions like diabetes, which affects 12.3% of the UAE population. By enabling regular symptom tracking and side-effect monitoring (even when patients are at home) the platform ensures proactive care management, and can also optimize early detection and screening of cancers.

Blaik Wilson, Cemplicity’s CEO, shared: “We are excited to bring Cemplicity to the UAE, a nation committed to healthcare excellence. With the private healthcare sector evolving at an impressive pace, partnering with such forward-thinking providers enables us to transform patient feedback into meaningful insights that enhance patient experiences and improve outcomes”.

Wilson added: “Globally, healthcare produces 30% of the world’s data volume. Aggregating and anonymizing patient-reported data not only uncovers trends and evaluates treatment outcomes but also advances the UAE’s broader ambition to lead in medical research and innovation”.

Also Read: Malak Trabelsi Loeb On Leadership And QIS 2025

With a presence in nine countries and partnerships with major healthcare providers like the UK’s National Health Service (NHS), Cemplicity has already redefined how hospitals and clinics leverage patient feedback. Its tools, known for achieving high survey response rates, help link patient experiences to organizational KPIs and Net Promoter Scores (NPS), enabling measurable improvements in operations, and clinical outcomes, while fostering a culture of continuous improvement.

For the UAE market, the platform has been specially adapted to local needs, offering multilingual support (including Arabic) and seamless integration with tools such as WhatsApp and various hospital management systems.